The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR. According to the study, although the prevalence rate of depression has gone up in the last decade, preference for cognitive behaviorContinue reading “Depression Drugs Market Delivers Higher Revenue Share As Contribution by Major Players”
Tag Archives: Novartis-AG
Anticancer Drugs Market Players Contribute Majorly towards Innovative Trends
The past decade has witnessed substantial developments for the development of targeted therapy for the treatment of cancer, with a number of relevant gene mutations being identified, which has resulted in the finding of drug targets and anticancer drugs, which are propelling changes in terms of data base technologies, which are related to the changesContinue reading “Anticancer Drugs Market Players Contribute Majorly towards Innovative Trends”